Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

The trial is testing a new easy-to-administer and patient-friendly sustained-release formulation of flucytosine, a key ...

A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV ...

Benjamin K. Chen, MD, PhD, discussed the next steps after the results of his study in genetic tagging showed promise in ...

Researchers assessed whether participation in Ryan White services improves outcomes among patients with hepatitis C virus and HIV coinfection.

A significant number of Americans living with HIV report experiencing stigma. Black and Hispanic/Latinx people living with diagnosed HIV experience more HIV stigma and more instan ...

A University of Utah professor is being recognized as one of Time's most influential people for his work in creating ...

A University of Utah professor is being recognized as one of Time's most influential people for his work in creating lenacapavir, a long-lasting HIV prevention and treatment drug.

Benjamin Chen, MD, PhD, of the Icahn School of Medicine at Mount Sinai, discusses the implications of his new study involving ...

Biotech bigwig Gilead Sciences, Inc. GILD is scheduled to report first-quarter 2025 results on April 24, after market close. The Zacks Consensus Estimate for sales and earnings is pegged at $6.83 ...

Why bats can harbor viruses like hantavirus and coronavirus—pathogens that are highly dangerous to humans—without becoming ...